October 13, 2017
Daiichi Sankyo said on October 12 that it has initiated joint research with the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) on the development of a genetic vaccine platform, utilizing its in-house developed novel nucleic acid delivery technology...read more